Trials / Conditions / Stage II Verrucous Carcinoma of the Oral Cavity

Stage II Verrucous Carcinoma of the Oral Cavity

11 registered clinical trials studyying Stage II Verrucous Carcinoma of the Oral Cavity — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoi NCT02123511	Mayo Clinic	Phase 2
Withdrawn	Photodynamic Therapy Using Temoporfin Before Surgery in Treating Patients With Recurrent Oral Cavity or Oropha NCT01718223	Roswell Park Cancer Institute	N/A
Terminated	Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC NCT01283178	Virginia Commonwealth University	Phase 1
Terminated	Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck Cancer NCT01254734	City of Hope Medical Center	N/A
Terminated	Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radi NCT01164566	Wake Forest University Health Sciences	N/A
Completed	L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For NCT01155609	University of Washington	N/A
Recruiting	Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck NCT01473784	Ohio State University Comprehensive Cancer Center	N/A
Completed	Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. NCT01469429	Ohio State University Comprehensive Cancer Center	Phase 1 / Phase 2
Completed	Freeze-Dried Black Raspberries in Preventing Oral Cancer Recurrence in High At-Risk Appalachian Patients Oral NCT01504932	Ohio State University Comprehensive Cancer Center	N/A
Completed	Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck NCT00470496	Roswell Park Cancer Institute	Phase 1
Withdrawn	Photodynamic Therapy With HPPH in Treating Patients With Squamous Cell Carcinoma of the Oral Cavity NCT02119728	Roswell Park Cancer Institute	Phase 2